Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03439306 · ClinicalTrials.gov registry record

Accuracy Validation of Belun Oxygen Saturation Pulse Oximeter FDA Submission Study

A clinical trial of Hypoxia, sponsored by Belun Technology Company Limited.

Completed
Registry status
11
Enrollment target
1
Study location

NCT03439306 is a study of Hypoxia that has completed, run by Belun Technology Company Limited. The registered enrollment target is 11 participants, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03439306, a study of Hypoxia, has completed, sponsored by Belun Technology Company Limited.

COMPLETED
Registry status
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the oxygen saturation accuracy performance of Belun Ring Oximeter placed on the index fingers during non-motion conditions

Conditions Studied

Interventions

  • DEVICE Pulse Oximeter

Study Locations (1)

Colorado

  • Clinimark, LLC - Louisville

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2017-03-15
Est. Completion 2017-03-17

Sponsor

Belun Technology Company Limited

6 total trials

What the Registry Record Tells You About NCT03439306

The ClinicalTrials.gov registry entry for NCT03439306 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower). The listed sponsor is Belun Technology Company Limited, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Pulse Oximeter is the first listed.

NCT03439306 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT03439306 about?

NCT03439306 is a clinical study titled "Accuracy Validation of Belun Oxygen Saturation Pulse Oximeter FDA Submission Study". The purpose of this study is to evaluate the oxygen saturation accuracy performance of Belun Ring Oximeter placed on the index fingers during non-motion conditions

What is the current status of trial NCT03439306?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2017-03-15. Estimated completion is 2017-03-17.

What conditions does trial NCT03439306 study?

This clinical trial studies the following conditions: Hypoxia.

What interventions are being tested in trial NCT03439306?

The interventions under investigation include: Pulse Oximeter (DEVICE).

Who is sponsoring clinical trial NCT03439306?

This trial is sponsored by Belun Technology Company Limited, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03439306 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.